Filing Manager
ORBIMED CAPITAL LLC
Reporting Manager
OrbiMed Capital LLC
Symbol
SIBN
Shares outstanding
42,827,451 shares
Disclosed Ownership
2,184,200 shares
Ownership
5.1%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 18:05:13 UTC
Date of event
30 Jun 2025
Previous filing
15 May 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"ORBIMED CAPITAL LLC disclosed 5.1% ownership in SI-BONE, Inc. Common Stock, par value $0.0001 per share (SIBN) on 30 Jun 2025."

Quick Takeaways

  • ORBIMED CAPITAL LLC filed SCHEDULE 13G/A for SI-BONE, Inc. Common Stock, par value $0.0001 per share (SIBN).
  • Disclosed ownership: 5.1%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 14 Aug 2025, 18:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
OrbiMed Capital LLC 5.1% 2,184,200 2,184,200 0 /s/ Carl L. Gordon Carl L. Gordon / Member
OrbiMed Advisors LLC 0.9% 394,779 0 394,779 /s/ Carl L. Gordon Carl L. Gordon / Member